Sign in: Staff/Students
New research published in the Journal of Epidemiology & Community Health shows that health investment in poorer areas has had a significant impact on health inequalities.
Since 2010 the National Health Service (NHS) in England has faced significant funding pressures in an apparent effort to reduce deficits following the economic crisis. Following prior record investment, NHS services received from 2010 to 2016 on average 1.3% additional funding, against demand increases of over 3% annually. Given rising pressures, many have questioned the sustainability of such budgetary pressures, given unparalleled scarcity in NHS history.
Researchers, from the University of Liverpool, Public Health Wales and Cardiff University, aimed to evaluate the specific impact this reduction in investment has had on health inequalities and *amenable mortality, deaths that ought not to happen with timely and quality healthcare.
The researchers undertook an analysis across 324 lower-tier local authorities in England, evaluating the impact of changes in funding allocations to health commissioners from 2007 to 2014 on spatial inequalities in age-standardised under-75 mortality rates for conditions amenable to healthcare for men and women.
The researchers found that more deprived areas received proportionally more funding between 2007 and 2014, though the reorganisation of commissioning in 2012 stalled this.
Funding increases to more deprived local areas accounted for a statistically significant reduction in inequalities in male amenable mortality between local areas of 13 deaths per 100 000.
Johnny Currie, Public health and primary care specialist doctor in Wales and lead author of the study, said: “Our study found NHS funding policy distributing investment towards poorer areas significantly narrowed inequalities in amenable mortality for men between affluent and poorer areas
“However the gains won in tackling these inequalities between 2007-2014 were far less than in previous years, while trends since 09/10 appear to be in reverse. Reduced NHS spending, lower redistribution to poorer areas and a distraction from tackling inequalities by central government given the focus on balancing budgets appear to be stalling narrowing entirely avoidable gaps in mortality between affluent and poorer communities
Benjamin Barr, Senior Clinical Lecturer in Applied Public Health, University of Liverpool, said: “Careful surveillance is needed to evaluate whether diminished allocations to more deprived areas in recent years and reduced NHS investment as a whole is impacting adversely on inequalities between groups.”
The full paper, entitled ‘Evaluating effects of recent changes in NHS resource allocation policy on inequalities in amenable mortality in England, 2007–2014: time-series analysis’, can be found here.
*Amenable mortality includes any death under 75 years old that ought not to happen in the presence of timely and quality healthcare. It is a marker of healthcare quality and comprises a significant portion of overall population mortality under 75.
You must be logged in to post a comment.
All recent news
14: Dame Louise Ellman and Professor William Hope
Play your part in #TeamLivUni
How we are safely welcoming live audiences back for Liverpool Literary Festival 2021
Our favourite images from Welcome Week 2021
Heseltine Institute report for LCR APPG leads calls for Westminster to deliver “clean, green and inclusive growth”
Liverpool is leading a new global network to bring together animal & human #coronavirus research communities.
Funded by @UKRI partners include @APHAgovuk @roslininstitute @Pirbright_Inst @Cambridge_Uni
#OneHealth #LivUniCovid @ThePandemicInst @livuniHLS https://bit.ly/3AEEqHr
Preventing the next global pandemics depends on the collective capacity of universities. For @Wonkhe this morning I’ve written about Liverpool, Covid-19 and @ThePandemicInst, and what next: https://wonkhe.com/blogs/if-pandemics-are-predictable-could-they-be-preventable/
Researchers from @livuniHLS have contributed to new research showing that llama antibodies have 'significant potential' as a #COVID19 treatment.
Published in @NatureComms today, the study was led by @RosFrankInst.
#LivUniCovid | @molvirol | @LivUni_IVES